胸主动脉损伤腔内治疗后的心血管重塑
本研究评估20例胸主动脉损伤年轻患者接受TEVAR后心脏与血管结构和功能重塑,中位随访5.0±3.5年。12例(55%)发生高血压,治疗超过3年者左室质量指数、脉搏波传导速度和升主动脉扩张更高。TEVAR与心血管重塑相关,可能诱导血压升高并促进主动脉和心脏损害。
要点
- TEVAR治疗胸主动脉损伤后55%年轻患者出现高血压。
- 治疗超过3年者左室质量指数、脉搏波传导速度和升主动脉扩张更高。
- TEVAR改变主动脉功能特性,可能诱导血压升高并促进靶器官损害。
核心结论
- TEVAR治疗胸主动脉损伤与心脏和血管重塑相关,即使年轻患者也可能出现血压升高及主动脉和心脏损害。
研究设计与样本
- 单中心评估20例胸主动脉损伤患者(18例男性,年龄41±14岁,11例使用Gore CTAG,9例使用Medtronic Valiant),于创伤后中位5.0±3.5年进行诊室及24小时血压、血管硬度、主动脉直径和左室质量指数评估。
主要发现
- 胸主动脉损伤后12例患者(55%)发生高血压。
- 按治疗时间分组,治疗超过3年的患者左室质量指数、脉搏波传导速度和升主动脉扩张更高。
临床怎么用
- TEVAR术后应对年轻患者进行长期血压监测和心血管重塑评估,尤其关注治疗超过3年者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic endovascular aortic repair (TEVAR) currently represents the gold standard of treatment for thoracic aortic injury (TAI). Nevertheless, there is an ongoing debate surrounding its safety and subsequent cardiovascular effects. Our aim is to assess heart and vascular structure and function remodeling after TEVAR in TAI young patients. METHODS: We evaluated 20 patients (18 men, age 41 ± 14 years, 11 treated with Gore CTAG, 9 with Medtronic Valiant) with office and 24-hr blood pressure (BP) with specific vascular stiffness analysis (Mobil-O-Graph), aortic diameters (computed tomography scan) and left ventricular mass index (LVMI echocardiogram). Evaluation was done after a median time of 5.0 ± 3.5 years from the trauma. RESULTS: After TAI 12 patients (55%) developed hypertension. When patients were divided according to treating time, those treated for more than 3 years show higher LVMI, PWV, and ascending aorta dilatation. CONCLUSIONS: Our study shows that TEVAR for TAI is associated with heart and vascular remodeling. The presence of TEVAR modifies aortic functional properties and could induce an increase in BP that can promote aortic and cardiac damage, even in young patients.
引用
- Vallerio P, Maloberti A, D'Alessio I, et al. Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury. Ann Vasc Surg. 2019. PMID: 31344466. doi:10.1016/j.avsg.2019.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。